ANDA 87185, held by Ivax Pharms. Ergoloid Mesylates.
As of Nov 15, 2026, ANDA 87185 (Hydrogenated Ergot Alkaloids), held by Ivax Pharms, was first approved by FDA on Nov 20, 1980, with 19 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Nov 20, 1980 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Hydrogenated Ergot Alkaloids1MG ยท tablet;sublingual | Ergoloid Mesylates | Discontinued |
| Jul 29, 2002 | Supplement 32Manufacturing | Approved | None posted |
| Jun 27, 2002 | Supplement 30Manufacturing | Approved | None posted |
| Mar 12, 2002 | Supplement 31Manufacturing | Approved | None posted |
| Jul 21, 2000 | Supplement 29Manufacturing | Approved | None posted |
| Jul 21, 2000 | Supplement 28Manufacturing | Approved | None posted |
| Jan 28, 2000 | Supplement 27Manufacturing | Approved | None posted |
| Nov 23, 1999 | Supplement 26Manufacturing | Approved | None posted |
| Aug 20, 1999 | Supplement 25Manufacturing | Approved | None posted |
| Dec 9, 1998 | Supplement 24Manufacturing | Approved | None posted |
| May 30, 1997 | Supplement 23Manufacturing | Approved | None posted |
| Nov 22, 1995 | Supplement 22Manufacturing | Approved | None posted |
| Jun 27, 1995 | Supplement 19Manufacturing | Approved | None posted |
| Aug 24, 1994 | Supplement 21Manufacturing | Approved | None posted |
| May 17, 1990 | Supplement 18Labeling | Approved | None posted |
| Aug 2, 1989 | Supplement 17Labeling | Approved | None posted |
| Aug 22, 1988 | Supplement 15Manufacturing | Approved | None posted |
| Feb 11, 1988 | Supplement 16Manufacturing | Approved | None posted |
| Feb 11, 1988 | Supplement 14Manufacturing | Approved | None posted |
| Feb 11, 1988 | Supplement 13Manufacturing | Approved | None posted |
| Nov 20, 1980 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters